Literature DB >> 6970775

Alloreactive cloned T cell lines. III. Accessory cell requirements for the growth of cloned cytolytic T lymphocytes.

C T Lutz, A L Glasebrook, F W Fitch.   

Abstract

We examined the role of accessory cells that cooperated with the cloned cytolytic T cell line, L3. Accessory cells and T cell growth factors (TCGF) acted synergistically to stimulate cloned L3 CTL to grow and produce cytolytic activity. Accessory cells were non-T, radioresistant, plastic adherent M phi-like cells that interacted with cloned L3 CTL via soluble factors. Peritoneal M phi, at low density, also cooperated with L3 cells but at high density, inhibited L3 cells. Both accessory and inhibitory M phi acted upon L3 CTL without the intervention of other T lymphocytes or nonadherent cells. Other published reports indicate that M phi may promote cytolytic activity indirectly, amplifying TCGF production by helper T lymphocytes. This report indicates that M phi may also promote cytolytic activity directly, amplifying the response of CTL to TCGF.

Mesh:

Substances:

Year:  1981        PMID: 6970775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.

Authors:  J F Sheridan; L Aurelian; A D Donnenberg; T C Quinn
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

2.  Synergy between interleukin-2 and a second factor in the long-term growth of human T cells.

Authors:  B J Mills; J E Shively; P S Mitsky; D H Hawke; S J Forman; C L Wright; C W Todd
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptide.

Authors:  H C Stevenson; G A Dekaban; P J Miller; C Benyajati; M L Pearson
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.